COPD

Digital

Digital biomarkers: Redefining respiratory care

Respiratory diseases, common examples of which include asthma and chronic obstructive pulmonary disease (COPD), affect one in five people in the UK.1 The economic burden of these

News

Study finds AZ's benralizumab a 'game-changer' in asthma

Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if it was used to treat acute asthma attacks

News

Sanofi's Dupixent scores double COPD win in US, China

Originally anticipated in June, the FDA action stands to make Sanofi and Regeneron's biologic blockbuster even bigger.

News

ICER mulls GSK COPD drugs ahead of next Medicare negotiation

The list for the next round of medicines that will be subject to Medicare price negotiations isn’t in yet, but the Institute for Clinical and Economic Review (ICER) reckons a chronic obstru

News

Businessmen gesticulating and discussing contents on a smartphone

ERS: Analysis of speech spots COPD flare-ups

Researchers have found that changes in speech recorded using a smartphone can be used to predict when a patient with chronic obstructive pulmonary disease (COPD) is at risk of an exacerbati

News

GSK says Nucala hits the target in new COPD trial

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<

Digital biomarkers: Redefining respiratory care

Study finds AZ's benralizumab a 'game-changer' in asthma

Sanofi's Dupixent scores double COPD win in US, China

ICER mulls GSK COPD drugs ahead of next Medicare negotiation

ERS: Analysis of speech spots COPD flare-ups

GSK says Nucala hits the target in new COPD trial

NHS to offer Wegovy to a million more people in England

Using AI-driven synthetic personas to take your insights fur...

COPD

Editor's Picks